May 15, 2017 / 3:53 AM / 3 months ago

Thermo Fisher in talks to buy Patheon: Bloomberg

Traders work at the post where shares of Patheon NV is traded on the floor of the New York Stock Exchange (NYSE) in New York City, U.S., July 21, 2016.Brendan McDermid

(Reuters) - Scientific instruments maker Thermo Fisher Scientific Inc (TMO.N) is in talks to buy Patheon NV (PTHN.N), Bloomberg reported late on Sunday.

Thermo Fisher and Patheon could not be reached for comment outside regular business hours.

An agreement between Thermo Fisher and the Dutch drug ingredients maker could be reached as early as this week, Bloomberg reported, citing people with knowledge of the matter.

The discussions could still falter, and there's no certainty a deal will be reached, Bloomberg added. bloom.bg/2qirdlR

Thermo Fisher has seen its stock rise over 21 percent in 2017, bringing its market value to about $67.1 billion, according to Thomson Reuters data.

Shares of Patheon have fallen about 9.4 percent this year, valuing the company at about $3.8 billion.

Reporting by Ismail Shakil in Bengaluru; Editing by Sunil Nair

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below